Skip to main content
Kent Academic Repository

Role of angiotensin receptor-neprilysin inhibitor in diabetic complications

Liu, Ying, Lu, Cun-Yu, Zheng, Yi, Zhang, Yu-Min, Qian, Ling-Ling, Li, Ku-Lin, Tse, Gary, Wang, Ru-Xing, Liu, Tong (2024) Role of angiotensin receptor-neprilysin inhibitor in diabetic complications. World journal of diabetes, 15 (5). pp. 867-875. E-ISSN 1948-9358. (doi:10.4239/wjd.v15.i5.867) (KAR id:106155)

Abstract

Diabetes mellitus is a prevalent disorder with multi-system manifestations, causing a significant burden in terms of disability and deaths globally. Angio-tensin receptor-neprilysin inhibitor (ARNI) belongs to a class of medications for treating heart failure, with the benefits of reducing hospitalization rates and mortality. This review mainly focuses on the clinical and basic investigations related to ARNI and diabetic complications, discussing possible physiological and molecular mechanisms, with insights for future applications.

Item Type: Article
DOI/Identification number: 10.4239/wjd.v15.i5.867
Projects: Tianjin Key Medical Discipline (Specialty) Construction Project, No. TJYXZDXK-029A
Uncontrolled keywords: Angiotensin receptor-neprilysin inhibitor; Diabetic mellitus; Complication
Subjects: R Medicine
Divisions: Divisions > Division of Natural Sciences > Kent and Medway Medical School
Funders: National Natural Science Foundation of China (https://ror.org/01h0zpd94)
SWORD Depositor: JISC Publications Router
Depositing User: JISC Publications Router
Date Deposited: 03 Jun 2024 11:59 UTC
Last Modified: 05 Nov 2024 13:11 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/106155 (The current URI for this page, for reference purposes)

University of Kent Author Information

  • Depositors only (login required):

Total unique views for this document in KAR since July 2020. For more details click on the image.